Fortrea stock jumps after agreed acquisition of WCT Early Phase Services
Fortrea Holdings shares rose about 3% in the afternoon after the company agreed to acquire the Early Phase Services division of Worldwide Clinical Trials, per an official company press release.
Shares of clinical research company Fortrea Holdings, NASDAQ:FTRE, rose 3% in afternoon trading after the company agreed to acquire the Early Phase Services division of Worldwide Clinical Trials. An official company press release said the transaction includes Worldwide Cli…